Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about BMY

Recent news which mentions BMY

< Previous 1 2 3 4 5 6 7 8 9
...
32 33 Next >
Generic Drug Maker Teva Clocks 13% Jump In Q3 Revenues, Tightens Annual Forecast
Tickers BMY NEWS NVO TEVA
Tags Health Care News pharmaceuticals
From Benzinga
Summit Therapeutics 'Unique Investment In Oncology,' Lead Drug Candidate Shows Promise Over Keytruda And Opdivo
Tickers BMY MRK NEWS SMMT
Tags Stories That Matter BMY Analyst Ratings
From Benzinga
How Is The Market Feeling About Bristol-Myers Squibb?
Tickers BMY
Tags Trading Ideas Short Ideas Short Sellers
From Benzinga
Bristol Myers Squibb Expects New Schizophrenia Treatment To Boost Long-Term Growth, Analysts Remain Cautious
Tickers BMY NEWS
Tags Large Cap Analyst Ratings Stories That Matter
From Benzinga
Stocks Tumble, Nasdaq 100 Selloffs As Tech Giants Disappoint, Crypto Companies Plummet: What's Driving Markets Thursday?
Tickers AAPL AMGN AMZN BKNG
Tags BMY TEAM Commodities
From Benzinga
Bristol Myers Squibb (BMY) Q3 2024 Earnings Call Transcript
Tickers BMY
Tags Recent Press Releases Market News BMY
From Motley Fool
Bristol Myers Squibb Boosts 2024 Outlook On Strong Demand For Blood Thinner Med, New Drugs Drive Q3 Profit
Tickers BMY NEWS
Tags Guidance BMY Stories That Matter
From Benzinga
Positive Outlook For Novartis As Company Capitalizes On Growing Treatment Opportunities, Analyst Highlights
Tickers ABBV AMGN BIIB BMY
Tags Expert Ideas BIIB LLY
From Benzinga
Lyell Immunopharma Downgraded, Analyst Flags Concerns Over Acquisition Strategy
Tickers BMY GILD LYEL NEWS
Tags Downgrades Expert Ideas Biotech
From Benzinga
Unpacking the Latest Options Trading Trends in Bristol-Myers Squibb
Tickers BMY
Tags Market News BMY Options
From Benzinga
800% Upside For This Biotech Stock - Analyst Initiates Coverage On Bladder Cancer Focused ImmunityBio
Tickers BMY IBRX MRK NEWS
Tags Expert Ideas Biotech Benzinga
From Benzinga
Why Is Evotec Stock Gaining Today?
Tickers BMY EVO NEWS
Tags AI Generated BMY Stories That Matter
From Benzinga
Alumis' Investigational Lead Candidate Supports Superior Profile Than Bristol Myers' Commercialized Drug, Analyst Sees 170% Stock Upside
Tickers ALMS BMY NEWS TAK
Tags Analyst Color Price Target Market News
From Benzinga
Johnson & Johnson Beats Wall Street Estimates. Is It Time to Buy, Sell, or Hold?
Tickers BMY JNJ
Tags Recent Press Releases BMY Market News
From Motley Fool
Cancer-Focused Perspective Therapeutics Stock Trades Lower After Drug Study Report
Tickers BMY CATX NEWS
Tags BMY CATX Trading Ideas
From Benzinga
Reviva Pharmaceuticals Schizophrenia Drug Demonstrates Strong Efficacy On Heels Of Bristol Myers, FDA Approval: Analyst
Tickers BMY NEWS RVPH
Tags Briefs General Top Stories
From Benzinga
Unveiling 11 Analyst Insights On Bristol-Myers Squibb
Tickers BMY
Tags BZI/AAR BMY Market News
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Tickers BMY ELV HIMS HUM
Tags BMY ELV Options
From Benzinga
S&P 500 Could Reach 6,300 In 12 Months, Says Goldman Sachs, Driven By 'Strong AI Demand' And 'Margin Expansion'
Tickers AAPL AI BMY GILD
Tags VRTX GOOG Top Stories
From Benzinga
Pfizer Stock Slump: Will Starboard's Billion-Dollar Bet Spark Rebound?
Tickers BMY CRM PFE
Tags Expert Ideas Biotech Benzinga
From Benzinga
Bristol Myers' $10B Cancer Drug Opdivo Scores Expanded Use FDA Approval For Lung Cancer In Pre And Post-Surgery Setting
Tickers BMY NEWS
Tags Stories That Matter BMY Large Cap
From Benzinga
2 Passive-Income Stocks to Load Up On in October
Tickers BMY LMT
Tags LMT Recent Press Releases BMY
From Motley Fool
This Is What Whales Are Betting On Bristol-Myers Squibb
Tickers BMY
Tags BMY Market News Options
From Benzinga
IGM Biosciences' New Found Focus: Pivots From Cancer To Autoimmune Diseases, Names New CEO
Tickers BMY IGMS NEWS
Tags Market News News Health Care
From Benzinga
Why Prime Medicine Stock Soared Nearly 12% Higher on Monday
Tickers BMY PRME
Tags PRME Recent Press Releases BMY
From Motley Fool
Prime Medicine Inks Cell Therapy Pact With Bristol Myers Squibb Worth Over $3.5B, Streamlines Pipeline
Tickers BMY NEWS PRME
Tags BMY Stories That Matter Trading Ideas
From Benzinga
3 Surprisingly Underrated Stocks to Buy Right Now
Tickers BMY MRNA PFE
Tags BMY Market News PFE
From Motley Fool
Absence of Black Box Warning For Bristol Myers' Schizophrenia Treatment Could Enhance Alzheimer's Psychosis Potential
Tickers ABBV BMY NEWS
Tags News Health Care Price Target
From Benzinga
14 Stocks Gain Momentum As August Inflation Comes In Below Expectations
Tickers BABA BHP BMY BP
Tags JD Top Stories NU
From Benzinga
Schizophrenia Treatment Revolution: FDA Approves Bristol Myers Squibb' Cobenfy As New Class Of Treatment In More Than 3 Decades
Tickers BMY NEWS PRTC
Tags FDA Biotech Benzinga
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
32 33 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.